New microgel encapsulation method paves the way for more efficient cell therapies

Sana Biotechnology licenses innovative immune-silent stem cell technology developed though Harvard’s Blavatnik Biomedical Accelerator

Protecting transplanted cells from immune attack is a serious challenge. As with any organ transplant, cell...

Mario Suva and Ramesh Shivdasani are tackling some of the toughest, meanest cancers to clear a path to better treatments.

• Suva and Shivdasani are using every approach in their arsenal to figure out what makes cancer cells arise from healthy tissue.
• Armed with enough new knowledge about how cancer arises, they want to take truer aim at cancer cells, the cancer cell lineage, and factors that make cells go awry.
• Their new approach to cancer management would combine gene and cell therapies to kill the cancer...

Chad Cowan is on a quest for the universal donor, which would make cell therapy available to populations – not just individuals.

• Harvard scientist Chad Cowan aims to make off-the-shelf cellular products, and democratize access to new medicines.
• His lab is working to make cellular therapies that can work for anyone, not just a single patient. 
• Their ambitious goal is to modify therapeutic cells that can be transplanted into many people, without being rejected.

...

Advances in engineering blood cells, treating diabetes, regenerating joints, and growing organs

On May 31, 2018, Harvard Stem Cell Institute (HSCI) faculty members shared their research updates at the Harvard Medical School (HMS) Alumni Reunion symposium. Their work showcased the breadth of research being conducted across the HSCI network, both at Harvard University and its...

Newly funded project advances stem cell research by forging collaboration across disciplines and institutions

The new HSCI Junior Faculty Program investigators, pictured left to right: Ya-Chieh Hsu, Isaac Chiu, Jun Huh, and Judith Agudo...